Apellis Pharmaceuticals Inc (APLS) is a biotechnology company listed on US.
Latest reported APLS revenue for 2025-12-31 was $1.00B. Net income was $22.4M. Revenue was up 28.5% from 2024-12-31 to 2025-12-31. APLS currently screens at market cap $2.29B.
Use this APLS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the APLS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the APLS SEC filings page. Lician reads the product cache first so this HTML stays unique to Apellis Pharmaceuticals Inc even when a live quote feed is slow.
Latest cached year on this hub. Full APLS income, balance, and cash tables.